AAAAAA

   
Results: 1-16 |
Results: 16
ECONOMIC-DEPENDENT, CAREGIVER-DEPENDENT, AND VENTILATOR-DEPENDENT STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS - PROSPECTIVE CORRELATION WITH ALS FUNCTIONAL RATING-SCALE, ISOMETRIC MUSCLE STRENGTH, PULMONARY-FUNCTION, SF-36, AND SICKNESS IMPACT PROFILE QUALITY-OF-LIFE MEASURES
Authors: BROOKS BR SHODIS KA LOTTO M SANJAK M ROELKE K BELDEN D PARNELL J DEWITT C WHEAT K
Citation: Br. Brooks et al., ECONOMIC-DEPENDENT, CAREGIVER-DEPENDENT, AND VENTILATOR-DEPENDENT STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS - PROSPECTIVE CORRELATION WITH ALS FUNCTIONAL RATING-SCALE, ISOMETRIC MUSCLE STRENGTH, PULMONARY-FUNCTION, SF-36, AND SICKNESS IMPACT PROFILE QUALITY-OF-LIFE MEASURES, Annals of neurology, 42(3), 1997, pp. 311-311
GUIDELINES FOR THE USE AND PERFORMANCE OF QUANTITATIVE OUTCOME MEASURES IN ALS CLINICAL-TRIALS
Authors: BRINKMANN JR ANDRES P MENDOZA M SANJAK M
Citation: Jr. Brinkmann et al., GUIDELINES FOR THE USE AND PERFORMANCE OF QUANTITATIVE OUTCOME MEASURES IN ALS CLINICAL-TRIALS, Journal of the neurological sciences, 147(1), 1997, pp. 97-111
A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: LOTZ B BROOKS B SANJAK M WEASLER C ROELKE K PARNELL J NEVILLE H RINGEL S BRINKMANN J SINGH K BURNS D PESTRONK A LOPATE G FLORENCE J BLUME G ELIOTT J MITSUMOTO H LEVIN K SZIRONY K CALDWELL M BOSCH P SMITH B VERHEIJDE J CARR S ENGEL WK VELAZQUEZ L MILLER J GRAVES M SEPULVEDA L GARCIA S SMITH R LICHT J GILLIE E SILVERMAN L OLNEY R YUEN E MELNICK M MASS J BRADLEY W SHARMA K HURTAK L MAYOR L OLANOW CW HAUSER R MALAPIRA T OLANOW E HOPKINS L WEISSMAN J PIANTA T POLAK M SIDDIQUE T SUFIT R CASEY P ROOS R SALAZARGRUESO E RICHMAN J KASARSKIS E ENGLISH T BOTTOMS B SHEFNER J LOGIGIAN E ODAKA B CORWIN C KUNCL R ROTHSTEIN J CLAWSON L CHAUDHRY V CORNBLATH D CORSE A BROMBERG M WALD J FORSHEW D LITCHY W WINDEBANK A BUSS J CAMPION J DAUBE JR SUBRAMONY SH VEDANARAYANAN V WEAVER R CROSSWHITE T KULA R ANSELMI G RIHA T SORRENTINO C HOLMLUND T WARNER C CAMANN M MILLARD C DONNENFELD H KLEINMAN A SIVAK M ALAMPUR U HOEHL J BRATTON J JUBELT B CARY G BARRY J DRUCKER J SAMAHA F SAMS L CLARKE A SCHWIEDERMAN D MENDELL J SAHENK Z KING W DOWNING K BIRD S SCHERER S BEALE J PFOHL D HEIMANPATTERSON T SHY M SUH Y GIULIANI M LACOMIS D DECESARE S HOLBACH S FENICHEL G HOWARD J ROBISON J TANDAN R PEET P CUSIMANO S KRUSINSKI P HILLEL A SUMI M VEALE M KONIKOW N BROOKE M CWIK V BURDEN N BOYD C DASILVA B STRONG M ROWE A FINDLATER K CASHMAN N ANTEL J FINCH L BRISSETTE J FISHER MR COOK T DEMETS D BECHHOFER R YOSHIHARA D WITTES J MCKHANN G ELLENBERG J GRIGGS RC LOWENTHAL D LEVINE R STAMBLER N CHARATAN M CEDARBAUM JM
Citation: B. Lotz et al., A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 46(5), 1996, pp. 1244-1249
MUSCULAR WEAKNESS ASSESSMENT - USE OF NORMAL ISOMETRIC STRENGTH DATA
Authors: FINISON LJ BROOKS BR RINGEL SP MUNSAT TL NEVILLE HE MURPHY JR ENGLAND JD LEE JY BRINKMANN JR ZITER F ALDERSON MK PETAJAN JH GAPPMAIER E MYLAR D BRYAN W HERBELIN J SMITH P MILLER RG ALMADA A MENDOZA M YU P ROELOFS RI SMITH SA GRAVES J SUFIT RL SANJAK M COOK T JUBELT B HELLER S CASEY P ROOS R SALESARGRUSEO E RICHMOND I ANDRES PL HEDLUND W
Citation: Lj. Finison et al., MUSCULAR WEAKNESS ASSESSMENT - USE OF NORMAL ISOMETRIC STRENGTH DATA, Archives of physical medicine and rehabilitation, 77(12), 1996, pp. 1251-1255
THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: BROOKS BR SANJAK M RINGEL S ENGLAND J BRINKMANN J PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K WITTES J CHARATAN M STAMBLER N CEDARBAUM JM
Citation: Br. Brooks et al., THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Archives of neurology, 53(2), 1996, pp. 141-147
CD8 AND CD4 T-CELL-MEDIATED POLYMYOSITIS COMPLICATING THE HTLV-1 ASSOCIATED MYELOPATHY - QUANTITATIVE-EVALUATION OF CORTICOSTEROID TREATMENT
Authors: WACLAWIK AJ FADIC R LOTZ BP BEINLICH BR LEWANDOSKI PJ SANJAK M BROOKS BR
Citation: Aj. Waclawik et al., CD8 AND CD4 T-CELL-MEDIATED POLYMYOSITIS COMPLICATING THE HTLV-1 ASSOCIATED MYELOPATHY - QUANTITATIVE-EVALUATION OF CORTICOSTEROID TREATMENT, Acta neurologica Scandinavica, 94(2), 1996, pp. 115-119
TEMPORAL DISTINCTION OF SPINAL AND BULBAR STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - VALIDATION WITH TIME-TO-FAILURE ANALYSIS EMPLOYING ALS FUNCTIONAL RATING-SCALE
Authors: BROOKS BR SHODIS KA SANJAK M BELDEN D
Citation: Br. Brooks et al., TEMPORAL DISTINCTION OF SPINAL AND BULBAR STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - VALIDATION WITH TIME-TO-FAILURE ANALYSIS EMPLOYING ALS FUNCTIONAL RATING-SCALE, Annals of neurology, 38(2), 1995, pp. 294-294
THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE
Authors: CEDARBAUM JM CHAPMAN C CHARATAN M STAMBLER N ANDREWS L ZHAN C RADKA S MORRISEY D LAKINGS D BROOKS BR SANJAK M PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K BITTLE L RINGEL S NEVILLE H BRINKMANN J
Citation: Jm. Cedarbaum et al., THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE, Clinical neuropharmacology, 18(6), 1995, pp. 500-514
A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: CEDARBAUM JM CHAPMAN C CHARATAN M STAMBLER N ANDREWS L ZHAN C RADKA S MORRISEY D LAKINGS D BROOKS BR SANJAK M PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K BITTLE L NEVILLE H RINGEL S BRINKMANN J WITTES J
Citation: Jm. Cedarbaum et al., A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Clinical neuropharmacology, 18(6), 1995, pp. 515-532
QUANTITATIVE NATURAL-HISTORY OF ISOMETRIC STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIPLE-SCLEROSIS - MEGASLOPES NORMALIZED TO A GENDER-SPECIFIED AND AGE-SPECIFIED NORMAL SUBJECT POPULATION DEMONSTRATE GENDER-SPECIFIC REGIONAL DIFFERENCES IN THE COURSE OF AMYOTROPHIC-LATERAL-SCLEROSIS COMPARED WITH MULTIPLE-SCLEROSIS
Authors: BROOKS BR SANJAK M BELDEN D
Citation: Br. Brooks et al., QUANTITATIVE NATURAL-HISTORY OF ISOMETRIC STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIPLE-SCLEROSIS - MEGASLOPES NORMALIZED TO A GENDER-SPECIFIED AND AGE-SPECIFIED NORMAL SUBJECT POPULATION DEMONSTRATE GENDER-SPECIFIC REGIONAL DIFFERENCES IN THE COURSE OF AMYOTROPHIC-LATERAL-SCLEROSIS COMPARED WITH MULTIPLE-SCLEROSIS, Annals of neurology, 36(2), 1994, pp. 274-274
ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
Authors: BROOKS BR SANJAK M NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K WITTES J BRITTAIN E STAMBLER N CHARATAN M CHAPMAN C CEDARBAUM JM
Citation: Br. Brooks et al., ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Neurology, 44(4), 1994, pp. 10000166-10000166
CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS
Authors: CEDARBAUM JM WITTES J BRITTAIN E BROOKS BR SANJAK M NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K STAMBLER N CHARATAN M CHAPMAN C
Citation: Jm. Cedarbaum et al., CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS, Neurology, 44(4), 1994, pp. 10000256-10000257
NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS - EFFECT OF SITE OF ONSET AND TIME AFTER ONSET ON SAMPLE-SIZE CALCULATIONS FOR CLINICAL THERAPEUTIC TRIALS EMPLOYING SLOPE OF STRENGTH LOSS
Authors: BROOKS BR LEWIS D RAWLING J SANJAK M BELDEN D HAKIM H DETAN Y SUFIT RL GAFFNEY J DEPAUL R
Citation: Br. Brooks et al., NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS - EFFECT OF SITE OF ONSET AND TIME AFTER ONSET ON SAMPLE-SIZE CALCULATIONS FOR CLINICAL THERAPEUTIC TRIALS EMPLOYING SLOPE OF STRENGTH LOSS, Annals of neurology, 34(2), 1993, pp. 297-297
STATISTICAL-ANALYSIS OF STRENGTH AND FUNCTION IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
Authors: LEWIS DH BELDEN D RAWLING J CAREY P SANJAK M BROOKS BR
Citation: Dh. Lewis et al., STATISTICAL-ANALYSIS OF STRENGTH AND FUNCTION IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Neurology, 43(4), 1993, pp. 258-258
RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES
Authors: BROOKS BR SANJAK M MITSUMOTO H SZIRONY K NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J CEDARBAUM JM CHARATAN M STAMBLER N WITTES J BRITTAIN E
Citation: Br. Brooks et al., RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES, Neurology, 43(4), 1993, pp. 416-416
THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) - PROSPECTIVE VALIDATION AND CHANGES OVER TIME
Authors: CEDARBAUM JM CHARATAN M STAMBLER N BROOKS BR SANJAK M MITSUMOTO WH SZIRONY K NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J WITTES J BRITTAIN E
Citation: Jm. Cedarbaum et al., THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) - PROSPECTIVE VALIDATION AND CHANGES OVER TIME, Neurology, 43(4), 1993, pp. 417-417
Risultati: 1-16 |